Histo-MExNet: A Unified Framework for Real-World, Cross-Magnification, and Trustworthy Breast Cancer Histopathology Journal: Nuclear Physics B
Enam Ahmed Taufik, Md Ahasanul Arafath, Abhijit Kumar Ghosh, Md. Tanzim Reza, Md Ashad Alam · 2026
Read Histo-MExNet: A Unified Framework for Real-World, Cross-Magnification, and Trustworthy Breast Cancer Histopathology Journal: Nuclear Physics B by Enam Ahmed Taufik, Md Ahasanul Arafath, Abhijit Kumar Ghosh, Md. Tanzim Reza, Md Ashad Alam (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2603-14416.txt.
Introduction
Taufika and co-authors present Histo-MExNet, a framework for breast cancer slide classification that holds up across magnifications. Many models wobble when zoom levels change and give no reason for their calls. The design mixes DenseNet, ConvNeXt, and EfficientNet experts behind a gate. A prototype module explains calls by example, and physics-based rules keep features true to tissue shape. Monte Carlo dropout gauges doubt on each call. On BreaKHis data, accuracy reaches about 97 percent under mixed-zoom training.
Catalog record
| CREATOR | Enam Ahmed Taufik, Md Ahasanul Arafath, Abhijit Kumar Ghosh, Md. Tanzim Reza, Md Ashad Alam |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48837 |
| LICENSE | http://creativecommons.org/licenses/by/4.0/ |
| RIGHTS | CC BY |
| SOURCE | arXiv |
Source: https://arxiv.org/abs/2603.14416
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Histo-MExNet: A Unified Framework for Real-World, Cross-Magnification, and Trustworthy Breast Cancer Histopathology Journal: Nuclear Physics B Enam Ahmed Taufik, Md Ahasanul Arafath, Abhijit Kumar Ghosh, Md. Tanzim Reza, Md Ashad Alam Abstract Accurate and reliable histopathological image classification is essential for breast cancer diagnosis. However, many deep learning models remain sensitive to magnification variability and lack interpretability. To address these challenges, we propose Histo-MExNet, a unified framework designed for scale-invariant and uncertainty-aware classification. The model integrates DenseNet, ConvNeXt, and EfficientNet backbones within a gated multi-expert architecture, incorporates a prototype learning module for example-driven interpretability, and applies physics-informed regularization to enforce morphology preservation and spatial coherence during feature learning. Monte Carlo Dropout is used to quantify predictive uncertainty. On the BreaKHis dataset, Histo-MExNet achieves 96.97% accuracy under multi-magnification training and demonstrates improved generalization to unseen magnification levels compared to single-expert models, while uncertainty estimation helps identify out-of-distribution samples and reduce overconfident errors, supporting a balanced combination of accuracy, robustness, and interpretability for clinical decision support. 1 Introduction Breast cancer remains a major cause of cancer-related mortality worldwide, making precise histological evaluation critical for reliable diagnosis and the planning of effective treatment strategies [ 4 , 70 ] . Histopathology is still regarded as the gold standard for grading malignancy, as it provides rich information on tissue architecture, cellular morphology, and mitotic activity [ 5 ] . In recent years, the introduction of Whole Slide Imaging (WSI) has transformed diagnostic workflows, moving pathology from conventional light microscopy towards digitally driven, computer-assisted analysis. This digitization has opened the door to the widespread use of deep learning methods, which seek to reduce inter-observer variability and enhance diagnostic consistency in routine practice [ 6 , 7 ] . Within this landscape, convolutional neural networks have emerged as particularly powerful tools for feature extraction, achieving performance that approaches that of human experts in tasks such as subtype classification and mitosis detection [ 8 , 9 , 13 ] . Despite these algorithmic developments, there are still several major barriers to the therapeutic use of deep learning in pathology. First, pathologists use high magnification for cellular details and low magnification for architectural context, making histopathological diagnosis intrinsically multi-scale. Nevertheless, the majority of current deep learning models are trained on patches with a single magnification, which prevents them from generalizing over the "scale gap" and degrades their performance when used on unseen magnifications [ 10 ] , [ 11 , 63 ] . Second, a significant obstacle is data heterogeneity. Significant class imbalance and changes in staining procedures reported in real-world datasets lead to models that overfit to specific laboratory conditions rather than learning robust morphological features [ 12 ] , [ 15 , 20 , 62 , 63 ] . Most importantly, typical CNNs’ "black-box" character erodes therapeutic trust. When faced with out-of-distribution artifacts, conventional models frequently assign high confidence to wrong predictions (overconfidence) and produce a deterministic softmax probability [ 17 ] . Clinicians are unable to determine whether a model’s choice is based on confounding noise or legitimate biological signals because of this lack of reliability. Few studies have incorporated uncertainty quantification or physics-informed restrictions directly into the training aim to enforce biological plausibility, despite current research on explainable AI [ 18 , 64 ] . To address these challenges, this study introduces Histo-MExNet, a unified framework for scale-invariant, uncertainty-aware classification. The proposed framework is motivated by the practical limitations observed in real-world datasets, where class imbalance and substantial morphological heterogeneity often restrict the effectiveness of contemporary convolutional backbones. In addition, variations in image magnification introduce domain shifts that degrade feature consistency and limit generalization across unseen resolutions. Histo-MExNet is designed to overcome these constraints through a gated multi-expert ensemble trained on mixed magnification data, enabling the model to learn complementary feature representations while improving robustness and scale-invariant generalization. The architecture further incorporates a physics-informed regularization strategy to preserve morphological consistency during training, along with a prototype learning module that provides case-based explanations. By integrating uncertainty quantification with interpretable prototype representations, the proposed framework aims to reduce overconfidence and enhance clinical credibility without compromising predictive performance. The main contributions of this work are summarized as follows: 1. We propose a gated multi-expert framework that integrates heterogeneous convolutional backbones to improve cross-magnification generalization and mitigate scale-dependent overfitting. 2. We introduce a prototype learning module that structures class representations through multiple learnable exemplars, enabling example-driven interpretability and more transparent decision boundaries. 3. We incorporate a physics-informed, domain-aware regularization strategy that constrains feature learning to preserve morphological coherence and reduce sensitivity to staining-related artifacts. 4. We conduct comprehensive evaluations under same-magnification, cross-magnification, and mixed-magnification training protocols, demonstrating state-of-the-art performance on the BreaKHis dataset and improved robustness to magnification-induced domain shift. This paper’s remaining sections are arranged as follows: Relevant literature on histopathological classification and uncertainty estimate is reviewed in Section 2 .Section 3 provides a detailed description of the proposed Histo-MExNet architecture, which includes the physics-informed loss and prototype module. Section 4 presents the experimental setup, Ablation research, and quantitative results. Finally, Section 5 discusses the clinical implications of our findings, and Section 6 presents the findings. 2 Literature review The transition from conventional manual microscopic inspection to digital pathology has revolutionized breast cancer diagnosis, enabling the application of deep learning methodologies for automated detection, subtyping, and prognostic forecasting. The initial emphasis of early research was on baseline classification with standard convolutional neural networks [ 37 , 35 , 33 , 29 , 28 , 65 , 66 ] . This demonstrated that automated analysis could distinguish between tissue that was benign and tissue that was cancerous [ 31 , 41 , 67 , 68 ] . A shift to increasingly complex tasks, like multi-class subtype classification, cross-magnification generalization, and clinically valid predictions, has been required due to the complexity of histopathology images. These problems have shown that typical CNNs have their limits and led to the creation of architectures that strike a compromise between accuracy, generalizability, and interpretabilit [ 60 , 61 ] . The backbone design of a histopathology classifier is essential for extracting discriminative information from intricate tissue textures. Early improvements depended a lot on making the network deeper to improve feature representation. Gour et al. [ 30 ] demonstrated that a 152-layer ResHist model could overcome the issue of vanishing gradients and identify intricate semantic features at both cellular and tissue levels. Saini and Susan [ 34 ] also dealt with class imbalance, which is a common problem in histopathology datasets, by using VGG16 and GAN-based augmentation together. Although these methods emphasized the advantages of depth and augmentation, further examination indicated that deep networks alone were inadequate for capturing the intricate structural patterns essential for dependable categorization. To solve this problem, DenseNet architectures, especially DenseNet201, have become the best way to get features from histopathology [ 43 , 44 ] . Dense connection improves the reuse of features, reduces the problem of disappearing gradients, and keeps both local and global tissue information. When used with textural descriptors like the Gray Level Co-Occurrence Matrix (GLCM), these networks are more sensitive to nuclear atypia and stromal patterns, which are critical for correctly telling the difference between subtypes. Recent studies showed that ConvNeXt and EfficientNet can achieve